Khalad Maliyar

531 total citations
62 papers, 286 citations indexed

About

Khalad Maliyar is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Khalad Maliyar has authored 62 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Dermatology, 24 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Khalad Maliyar's work include Psoriasis: Treatment and Pathogenesis (21 papers), Dermatology and Skin Diseases (19 papers) and Autoimmune Bullous Skin Diseases (10 papers). Khalad Maliyar is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (21 papers), Dermatology and Skin Diseases (19 papers) and Autoimmune Bullous Skin Diseases (10 papers). Khalad Maliyar collaborates with scholars based in Canada, United States and Brazil. Khalad Maliyar's co-authors include Muskaan Sachdeva, Asfandyar Mufti, R. Gary Sibbald, Jensen Yeung, Cathryn Sibbald, Melinda Gooderham, Ashley O’Toole, Elena Pope, Yuliya Lytvyn and Jorge R. Georgakopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

Khalad Maliyar

49 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalad Maliyar Canada 9 185 101 53 51 41 62 286
Mónica Munera‐Campos Spain 9 144 0.8× 64 0.6× 54 1.0× 23 0.5× 24 0.6× 21 221
Crystal Aguh United States 14 304 1.6× 43 0.4× 70 1.3× 48 0.9× 38 0.9× 46 517
Irina Turchin Canada 13 256 1.4× 170 1.7× 64 1.2× 63 1.2× 51 1.2× 44 424
Adriana Guana United States 16 348 1.9× 260 2.6× 69 1.3× 39 0.8× 86 2.1× 25 497
Teresa Grieco Italy 10 166 0.9× 37 0.4× 68 1.3× 51 1.0× 52 1.3× 42 333
Arjun M. Bashyam United States 8 176 1.0× 85 0.8× 93 1.8× 44 0.9× 18 0.4× 26 292
Ji Yeon Byun South Korea 11 183 1.0× 42 0.4× 59 1.1× 15 0.3× 25 0.6× 38 320
Enes Hajdarbegovic Netherlands 9 121 0.7× 160 1.6× 72 1.4× 69 1.4× 40 1.0× 18 315
Sophie Grande France 8 119 0.6× 87 0.9× 74 1.4× 51 1.0× 16 0.4× 10 230
Didem Didar Balcı Türkiye 9 174 0.9× 95 0.9× 10 0.2× 34 0.7× 18 0.4× 26 306

Countries citing papers authored by Khalad Maliyar

Since Specialization
Citations

This map shows the geographic impact of Khalad Maliyar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalad Maliyar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalad Maliyar more than expected).

Fields of papers citing papers by Khalad Maliyar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalad Maliyar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalad Maliyar. The network helps show where Khalad Maliyar may publish in the future.

Co-authorship network of co-authors of Khalad Maliyar

This figure shows the co-authorship network connecting the top 25 collaborators of Khalad Maliyar. A scholar is included among the top collaborators of Khalad Maliyar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalad Maliyar. Khalad Maliyar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maliyar, Khalad, et al.. (2025). Disease severity and pruritus treatment outcomes in prurigo nodularis: A systematic review of randomized-controlled trials. Journal of the American Academy of Dermatology. 93(1). 263–265. 1 indexed citations
2.
Maliyar, Khalad, et al.. (2025). Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review. Journal of the American Academy of Dermatology. 92(5). 1093–1095. 1 indexed citations
3.
Maliyar, Khalad, et al.. (2024). Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review. Journal of the American Academy of Dermatology. 91(1). 156–158.
4.
Liu, Nancy, Jorge R. Georgakopoulos, Khalad Maliyar, et al.. (2024). Development of Vitiligo in Patients Treated With BRAF/MEK Inhibitors: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 28(2). 200–201.
5.
Maliyar, Khalad, et al.. (2024). Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review. Journal of the American Academy of Dermatology. 92(1). 135–137. 1 indexed citations
6.
7.
Georgakopoulos, Jorge R., et al.. (2024). Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study. Journal of the American Academy of Dermatology. 91(5). 936–939. 5 indexed citations
8.
Mansour, Mark, Khalad Maliyar, Muskaan Sachdeva, et al.. (2024). 53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada. Journal of the American Academy of Dermatology. 91(3). AB294–AB294.
9.
Sachdeva, Muskaan, Yuliya Lytvyn, Khalad Maliyar, et al.. (2023). Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review. Journal of the American Academy of Dermatology. 90(2). 392–395. 6 indexed citations
10.
Georgakopoulos, Jorge R., et al.. (2023). Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study. Journal of the American Academy of Dermatology. 89(6). 1308–1311. 7 indexed citations
11.
Maliyar, Khalad, et al.. (2023). Use of risankizumab in two HIV-positive patients with psoriasis. JAAD Case Reports. 33. 54–55. 5 indexed citations
12.
Sachdeva, Muskaan, Asfandyar Mufti, Khalad Maliyar, et al.. (2021). A Review of COVID-19 Chilblains-like Lesions and Their Differential Diagnoses. Advances in Skin & Wound Care. 34(7). 348–354. 2 indexed citations
13.
Sachdeva, Muskaan, Asfandyar Mufti, Patrick Kim, Khalad Maliyar, & Cathryn Sibbald. (2021). Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review. Journal of the American Academy of Dermatology. 85(4). 1011–1013. 3 indexed citations
14.
Mufti, Asfandyar, Yuliya Lytvyn, Khalad Maliyar, Muskaan Sachdeva, & Jensen Yeung. (2020). Drugs associated with development of pityriasis rubra pilaris: A systematic review. Journal of the American Academy of Dermatology. 84(4). 1071–1081. 6 indexed citations
15.
Maliyar, Khalad, et al.. (2020). Development of morphea in patients receiving biologic therapies: A systematic review. Journal of the American Academy of Dermatology. 84(4). 1081–1085. 4 indexed citations
16.
Mufti, Asfandyar, Muskaan Sachdeva, Khalad Maliyar, & R. Gary Sibbald. (2020). Squamous cell carcinoma arising within discoid lupus erythematous lesions: A systematic review. JAAD International. 2. 1–4. 3 indexed citations
17.
Mufti, Asfandyar, et al.. (2020). Full Body Skin Examination Practices Among Canadian Dermatologists: Results of a Nationwide Survey. Journal of Cutaneous Medicine and Surgery. 25(2). 212–215.
18.
Mufti, Asfandyar, Muskaan Sachdeva, Patrick Kim, et al.. (2020). A systematic review of eczematous eruptions in patients receiving biologic therapy. Journal of the American Academy of Dermatology. 85(6). 1630–1635. 5 indexed citations
19.
Maliyar, Khalad, et al.. (2020). Real‐world experience of dupilumab in the treatment of moderate‐to‐severe atopic dermatitis. International Journal of Dermatology. 59(10). e361–e363. 7 indexed citations
20.
Sachdeva, Muskaan, Asfandyar Mufti, Khalad Maliyar, Yuliya Lytvyn, & Jensen Yeung. (2020). Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment. Journal of the American Academy of Dermatology. 83(2). 579–586. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Munera‐Campos Breakdown of academic impact, for papers by Crystal Aguh Breakdown of academic impact, for papers by Irina Turchin Breakdown of academic impact, for papers by Adriana Guana Breakdown of academic impact, for papers by Teresa Grieco Breakdown of academic impact, for papers by Arjun M. Bashyam Breakdown of academic impact, for papers by Ji Yeon Byun Breakdown of academic impact, for papers by Enes Hajdarbegovic Breakdown of academic impact, for papers by Sophie Grande Breakdown of academic impact, for papers by Didem Didar Balcı
Rankless by CCL
2026